Literature DB >> 31080263

Hereditary methemoglobinemia in a cyanotic cat presented for ovariohysterectomy.

Emily Vasiliadou1, Vasiliki Karakitsou1, George Kazakos1, Ioannis L Oikonomidis1, Theodora K Tsouloufi1, Panagiotis Kosmas1, Osheiza Y Abdulmalik1, Christos Koutinas1, Urs Giger1, Mathios E Mylonakis1.   

Abstract

A 1-year-old, female, domestic shorthair cat with a history of cyanotic mucous membranes for several months was referred for ovariohysterectomy. Blood samples exhibited a noticeably brownish discoloration, while laboratory screening revealed mild-to-moderate erythrocytosis and near normal partial arterial oxygen pressure. Blood methemoglobin content was 41% of total hemoglobin concentration, and erythrocytic methemoglobin reductase activity was < 1% compared with control samples. A diagnosis of hereditary methemoglobinemia was established. After an intravenous injection of methylene blue, the cat's mucous membranes became transiently pink, and the ovariohysterectomy was uneventful. Methylene blue may have improved safety during anesthesia and surgery. Hereditary methemoglobinemia should be considered in persistently cyanotic cats with normal partial arterial oxygen pressure and lack of evidence of cardiopulmonary disease, anemia, or toxin exposure.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31080263      PMCID: PMC6463781     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  14 in total

1.  Anesthesia case of the month. Methemoglobinemia.

Authors:  Lydia Love; Michael Singer
Journal:  J Am Vet Med Assoc       Date:  2013-03-15       Impact factor: 1.936

2.  A case with quadriparetic cerebral palsy and cyanosis: congenital methemoglobinemia.

Authors:  Selman Gokalp; Emin Unuvar; Fatma Oguz; Ayse Kilic; Mujgan Sidal
Journal:  Pediatr Neurol       Date:  2005-08       Impact factor: 3.372

Review 3.  Pathogenesis, laboratory diagnosis, and clinical implications of erythrocyte enzyme deficiencies in dogs, cats, and horses.

Authors:  John W Harvey
Journal:  Vet Clin Pathol       Date:  2006-06       Impact factor: 1.180

4.  Relation of endogenous Heinz bodies to disease and anemia in cats: 120 cases (1978-1987).

Authors:  M M Christopher
Journal:  J Am Vet Med Assoc       Date:  1989-04-15       Impact factor: 1.936

5.  Congenital Methemoglobinemia Type II-Clinical Improvement with Short-Term Methylene Blue Treatment.

Authors:  Monica S Cooper; Melinda Randall; Margaret Rowell; Margaret Charlton; Anthea Greenway; Chris Barnes
Journal:  Pediatr Blood Cancer       Date:  2015-11-17       Impact factor: 3.167

6.  Clinical assessment of repeated propofol-associated anesthesia in cats.

Authors:  Carla Rohrer Bley; Malgorzata Roos; Jill Price; Katja Ruess-Melzer; Julia Buchholz; Valerie Poirier; Barbara Kaser-Hotz
Journal:  J Am Vet Med Assoc       Date:  2007-11-01       Impact factor: 1.936

7.  Determination of methemoglobin and hemoglobin levels in small volume samples.

Authors:  Francoise Arnaud; Adam Higgins; Richard McCarron; Paula F Moon-Massat
Journal:  Artif Cells Nanomed Biotechnol       Date:  2016-03-02       Impact factor: 5.678

8.  Methylene blue can be used to treat methemoglobinemia in cats without inducing Heinz body hemolytic anemia.

Authors:  W K Rumbeiha; F W Oehme
Journal:  Vet Hum Toxicol       Date:  1992-04

9.  Congenital methemoglobinemia in a dog with a promoter deletion and a nonsynonymous coding variant in the gene encoding cytochrome b₅.

Authors:  J A McKenna; J Sacco; T T Son; L A Trepanier; M B Callan; J W Harvey; J W Arndt
Journal:  J Vet Intern Med       Date:  2014-08-21       Impact factor: 3.333

10.  Long-term Treatment with Methylene Blue in a Dog with Hereditary Methemoglobinemia Caused by Cytochrome b5 Reductase Deficiency.

Authors:  J A Jaffey; M R Harmon; N A Villani; E K Creighton; G S Johnson; U Giger; J R Dodam
Journal:  J Vet Intern Med       Date:  2017-09-29       Impact factor: 3.333

View more
  2 in total

1.  Clinical, metabolic, and molecular genetic characterization of hereditary methemoglobinemia caused by cytochrome b5 reductase deficiency in 30 dogs.

Authors:  J A Jaffey; N S Reading; O Abdulmalik; R Kreisler; G Bullock; A Wiest; N A Villani; T Mhlanga-Mutangadura; G S Johnson; L A Cohn; N Isaza; J W Harvey; U Giger
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

2.  Clinical, metabolic, and genetic characterization of hereditary methemoglobinemia caused by cytochrome b5 reductase deficiency in cats.

Authors:  Jared A Jaffey; N Scott Reading; Urs Giger; Osheiza Abdulmalik; Ruben M Buckley; Sophie Johnstone; Leslie A Lyons
Journal:  J Vet Intern Med       Date:  2019-10-25       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.